Use of biologically synthesized antimicrobial nanoparticles for improving peritoneal dialysis technique: a translational research perspective
Dinesh Kumar
摘要:Peritoneal dialysis (PD) is a well-established renal replacement therapy (RRT) for end-stage renal failure (ESRF)[1] and offers certain clear advantages over hemodialysis[2].However,PD is often associated with a high risk of infection of the intraperitoneal cavity,subcutaneous tunnel and catheter exit site,which may subsequently form microbial biofilms[1].Generally,a majority of PD patients suffer from bacterial and fungal infections and if the infection(s) is diagnosed timely,they can be resolved by appropriate antibiotic treatment.
机标关键词:
分类号:R459.5(治疗学)
论文发表日期:2016-01-01
在线出版日期:2025-08-15(本平台首次上网日期,不代表文献的发表时间)
生物医学研究杂志(英文版)

生物医学研究杂志(英文版)

ISSN:1007-4368
年,卷(期):2016,30(5)
所属栏目:PERSPECTIVE